<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schmit N</submitter><funding>Medical Research Council</funding><funding>Community Jameel</funding><funding>Wellcome Trust</funding><pagination>RP88283</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10957170</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Large reductions in the global malaria burden have been achieved, but plateauing funding poses a challenge for progressing towards the ultimate goal of malaria eradication. Using previously published mathematical models of &lt;i>Plasmodium falciparum&lt;/i> and &lt;i>Plasmodium vivax&lt;/i> transmission incorporating insecticide-treated nets (ITNs) as an illustrative intervention, we sought to identify the global funding allocation that maximized impact under defined objectives and across a range of global funding budgets. The optimal strategy for case reduction mirrored an allocation framework that prioritizes funding for high-transmission settings, resulting in total case reductions of 76% and 66% at intermediate budget levels, respectively. Allocation strategies that had the greatest impact on case reductions were associated with lesser near-term impacts on the global population at risk. The optimal funding distribution prioritized high ITN coverage in high-transmission settings endemic for &lt;i>P. falciparum&lt;/i> only, while maintaining lower levels in low-transmission settings. However, at high budgets, 62% of funding was targeted to low-transmission settings co-endemic for &lt;i>P. falciparum&lt;/i> and &lt;i>P. vivax&lt;/i>. These results support current global strategies to prioritize funding to high-burden &lt;i>P. falciparum&lt;/i>-endemic settings in sub-Saharan Africa to minimize clinical malaria burden and progress towards elimination, but highlight a trade-off with 'shrinking the map' through a focus on near-elimination settings and addressing the burden of &lt;i>P. vivax&lt;/i>.</pubmed_abstract><journal>eLife</journal><pubmed_title>Modeling resource allocation strategies for insecticide-treated bed nets to achieve malaria eradication.</pubmed_title><pmcid>PMC10957170</pmcid><funding_grant_id>10.35802/220900</funding_grant_id><funding_grant_id>220900/Z/20/Z</funding_grant_id><funding_grant_id>MR/R015600/1</funding_grant_id><pubmed_authors>Winskill P</pubmed_authors><pubmed_authors>White MT</pubmed_authors><pubmed_authors>Charles GD</pubmed_authors><pubmed_authors>Ghani AC</pubmed_authors><pubmed_authors>Hauck K</pubmed_authors><pubmed_authors>Schmit N</pubmed_authors><pubmed_authors>Pianella M</pubmed_authors><pubmed_authors>Topazian HM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modeling resource allocation strategies for insecticide-treated bed nets to achieve malaria eradication.</name><description>Large reductions in the global malaria burden have been achieved, but plateauing funding poses a challenge for progressing towards the ultimate goal of malaria eradication. Using previously published mathematical models of &lt;i>Plasmodium falciparum&lt;/i> and &lt;i>Plasmodium vivax&lt;/i> transmission incorporating insecticide-treated nets (ITNs) as an illustrative intervention, we sought to identify the global funding allocation that maximized impact under defined objectives and across a range of global funding budgets. The optimal strategy for case reduction mirrored an allocation framework that prioritizes funding for high-transmission settings, resulting in total case reductions of 76% and 66% at intermediate budget levels, respectively. Allocation strategies that had the greatest impact on case reductions were associated with lesser near-term impacts on the global population at risk. The optimal funding distribution prioritized high ITN coverage in high-transmission settings endemic for &lt;i>P. falciparum&lt;/i> only, while maintaining lower levels in low-transmission settings. However, at high budgets, 62% of funding was targeted to low-transmission settings co-endemic for &lt;i>P. falciparum&lt;/i> and &lt;i>P. vivax&lt;/i>. These results support current global strategies to prioritize funding to high-burden &lt;i>P. falciparum&lt;/i>-endemic settings in sub-Saharan Africa to minimize clinical malaria burden and progress towards elimination, but highlight a trade-off with 'shrinking the map' through a focus on near-elimination settings and addressing the burden of &lt;i>P. vivax&lt;/i>.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-22T13:01:54.699Z</modification><creation>2025-04-06T00:27:08.268Z</creation></dates><accession>S-EPMC10957170</accession><cross_references><pubmed>38329112</pubmed><doi>10.7554/eLife.88283</doi></cross_references></HashMap>